Akribes Biomedical GmbH
Back to list
Facts
- Founded
- Staff
- 5
- Organization type
- RDM medtech
Profile
Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.
Similar companies in RDM medtech
Akribes Biomedical GmbH
- Organization type
- RDM medtech
Baxter Medical Products GmbH
- Organization type
- RDM medtech
- Region
- Vienna
- Cluster
- LISAvienna
- Topic
-
biological-derived devices
single-use devices
resuable devices
ICT Innovation in Clinical Trials GmbH
- Organization type
- RDM medtech
- Region
- Vienna
- Cluster
-
Medical Technology Cluster
LISAvienna - Topic
-
telemedicine and e-health
software for medicine
S2-Engineering GmbH
- Organization type
- RDM medtech
- Region
- Upper Austria
Contact
Contact: